AUSTRALASIA
Sanofi v Eremad Pty Ltd [2013] ATMO 94
This matter concerned an opposition to registration of the mark CLOVIX 75 in respect of class 5 Pharmaceutical preparations being products containing clopidogrel. The mark was opposed by French...
This matter concerned an opposition to registration of the mark CLOVIX 75 in respect of class 5 Pharmaceutical preparations...
Read More
AUSTRALASIA
Pfizer Products Inc v Global Exporters Limited [2013] ATMO 92
This case concerned an opposition by Pfizer to the mark VEGETAL VIGRA in respect of class 5 health food supplements. Pfizer manufactures and markets the drug ‘Viagra’ for treatment of...
This case concerned an opposition by Pfizer to the mark VEGETAL VIGRA in respect of class 5 health food...
Read More
AUSTRALASIA
DNA Products Aust Pty Ltd v Botany Essentials Pty Limited [2013] ATMO 82
DNA Products Aust Pty Ltd opposed the registration of a trade mark for DNA SERUM within a double helix (reproduced below) covering cosmetics. The opponent pressed grounds under sections 41,...
DNA Products Aust Pty Ltd opposed the registration of a trade mark for DNA SERUM within a double helix...
Read More
AUSTRALASIA
Australian Trade Marks Office’s Fusion on INN Stems
The Australian Trade Marks Office has, in recent years, taken a very strict approach with regard to pharmaceutical trade marks that include a word having an INN stem. ...
The Australian Trade Marks Office has, in recent years, taken a very strict approach with regard to pharmaceutical trade...
Read More
India raises bar for pharmaceutical patents
India is one of the fastest growing economies in the world and one of the most attractive destinations for foreign investments, particularly for Western pharmaceutical companies.
India is one of the fastest growing economies in the world and one of the most attractive destinations for...
Read More
AUSTRALASIA
Pharmaceutical Patents Review Recommends Restriction of PTEs/SPCs
In our news alert of 21 November 2012 we drew attention to the Review of Pharmaceutical Patents which was announced by the Australian Government and we raised concerns about...
In our news alert of 21 November 2012 we drew attention to the Review of Pharmaceutical Patents which was...
Read More
AUSTRALASIA
Swedish Biotech Exports – more than ABBA, IKEA and Volvo…?
For a small country such as Sweden, biotechnology, which accounts for 20% of Sweden’s net exports, occupies an important place in the Swedish economy. With a host of some...
For a small country such as Sweden, biotechnology, which accounts for 20% of Sweden’s net exports, occupies an important...
Read More
AUSTRALASIA
Final Report of a Senate Committee Inquiry into Gene Patents
Further to our recent News Alert on the “Gene Patent Debate” the final report of a Senate Committee Inquiry into the impact of patenting of human genes and genetic...
Further to our recent News Alert on the “Gene Patent Debate” the final report of a Senate Committee Inquiry...
Read More
AUSTRALASIA
The Gene Patent Debate – Bill Seeks to Exclude Biological Materials from Patentability
Yesterday, NSW Liberal Senator Bill Heffernan, introduced the Patent Amendment (Human Genes and Biological Materials) Bill 2010 into Federal Parliament. The Bill has the potential for significant ramifications for...
Yesterday, NSW Liberal Senator Bill Heffernan, introduced the Patent Amendment (Human Genes and Biological Materials) Bill 2010 into Federal...
Read More
AUSTRALASIA
H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70
The Full Court of the Federal Court of Australia has recently handed down its decision in the Australian round of litigation relating to Lundbeck’s patent for the antidepressant Escitalopram...
The Full Court of the Federal Court of Australia has recently handed down its decision in the Australian round...
Read More
AUSTRALASIA
Sigma Pharmaceuticals (Australia) v Wyeth
In the recent Australian Federal Court decision of Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 595, Wyeth were successful in preventing Sigma’s launch of a generic version...
In the recent Australian Federal Court decision of Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 595, Wyeth...
Read More